Sign in

CIK 0002023658

  • Non-accelerated filer
  • Smaller reporting company
  • Emerging growth company

Bicara Therapeutics Inc.

Sign in to watch
Ticker
BCAX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 617-468-4219
Business address
116 HUNTINGTON AVENUE SUITE 703, BOSTON, MA, 02116
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$400,716
in 1 filing, $401K under 10b5-1 plans

Net −$400,716. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Cohlhepp Ryan −$401K President, COO & Interim CEO sold 9% of stake
Date Insider Transaction Shares Price Value Owned after
2026-06-09 Robertson Scott M. Director Grant or award · Stock Option (Right to Buy) +19,475 19,475
2025-06-09 Robertson Scott M. Director Grant or award · Stock Option (Right to Buy) +23,746 23,746
2024-09-12 Robertson Scott M. Director Grant or award · Stock Option (Right to Buy) +23,746 23,746

Page 1 of 1 · 3 trades